Theravance Biopharma TBPH
NASDAQ TBPH
$17.08 +0.00 (+0.00%)
As of: Sep 4, 2026 · 3:20 PM EDT

Theravance Biopharma (TBPH) Sales of Property, Plant and Equipment (2018 - 2023)

Analysis

Theravance Biopharma (TBPH) Sales of Property, Plant and Equipment (2018 - 2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Sales of Property, Plant and Equipment (Qtr)
1 Vertex Pharmaceuticals 138.43 Bn 130.58 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -
3 Argenx Se 63.34 Bn 58.15 Bn 1.37 Bn -
4 Moderna 57.98 Bn 52.85 Bn 52.00 Mn -
5 Revolution Medicines 43.98 Bn 43.98 Bn - -
6 BeOne Medicines 39.92 Bn 34.82 Bn 1.53 Bn 5.85 Mn
7 Alnylam Pharmaceuticals 35.42 Bn 32.11 Bn 992.69 Mn -
8 Royalty Pharma 28.42 Bn 27.58 Bn - -
9 Insmed 27.36 Bn 26.20 Bn 358.27 Mn -
10 Theravance Biopharma 882.21 Mn 494.56 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 1.30 Mn
Mar 31, 2023 210,000.00
Jun 30, 2022 17,000.00
Mar 31, 2022 1.85 Mn
Dec 31, 2020 29,000.00
Sep 30, 2020 34,000.00
Mar 31, 2018 17,000.00